Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -7.97
- Piotroski Score 4.00
- Grade Buy
- Symbol (SSKN)
- Company STRATA Skin Sciences, Inc.
- Price $3.10
- Changes Percentage (1.31%)
- Change $0.04
- Day Low $3.10
- Day High $3.10
- Year High $7.00
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/25/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.30
- Trailing P/E Ratio -0.95
- Forward P/E Ratio -0.95
- P/E Growth -0.95
- Net Income $-10,830,000
Income Statement
Quarterly
Annual
Latest News of SSKN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Strata Skin Sciences Inc (SSKN) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...
An equity raise generated $2.1 million by selling 665,136 shares. In Q3 2024, revenue per XTRAC device grew by 2%, gross margin improved to 60.3%, and operating expenses decreased to $5.2 million....
By Yahoo! Finance | 1 week ago
